Bio Path Holdings Inc (BPTH)

[blairsoldman]

The link says the study started in May 2016. WOW. Those were the days!!! I remember we on this message board thought we would have results by the end of 2017 and we would not only be rich but would have helped humanity overcome another scourge.

The stock hit $638 (pre 200:1 RSS adjusted). Happy days.

It would be kinda interesting to know what progress there is. How many of the 108 (if any) have actually been in treatment and if any have shown remission. I recall that it started with needing 21 (or thereabouts), how the heck did it get to 108?

The web site says:
BP1002 (Liposomal Bcl2 Antisense)

Bio-Path is planning to initiate a Phase 1 clinical trial of BP1002 in patients with follicular lymphoma, the most common form of non-Hodgkin’s lymphoma (NHL) in 2017.

Still planning for 2017 I see - have they missed the boat?

I stick with my belief that this was a hoax from the start and any remaining stock holders (such as me) are just being strung along in the hope we don't wise up and sue. Has anyone been to the office address to see if it looks like a real operation, not just a conman and secretary living it up.